UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Does the Hepatitis B Antigen HBx Promote the Appearance of Liver Cancer Stem Cells?

Cancer research (Chicago, Ill.), 2011-05, Vol.71 (10), p.3701-3708

2011

Volltextzugriff (PDF)

IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma

Cancer research (Chicago, Ill.), 2018-05, Vol.78 (9), p.2332-2342

2018

Volltextzugriff (PDF)

Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13), p.3679-3692

2021

Volltextzugriff (PDF)

AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells

Cancer research (Chicago, Ill.), 2012-09, Vol.72 (17), p.4394-4404

2012

Volltextzugriff (PDF)

PAK4 Phosphorylates p53 at Serine 215 to Promote Liver Cancer Metastasis

Cancer research (Chicago, Ill.), 2016-10, Vol.76 (19), p.5732-5742

2016

Volltextzugriff (PDF)

Mechanisms through Which Hypoxia-Induced Caveolin-1 Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma

Cancer research (Chicago, Ill.), 2016-12, Vol.76 (24), p.7242-7253

2016

Volltextzugriff (PDF)

Abstract 5156: The roles of x-linked Midline 1 interacting protein 1 (MID1IP1) in gender disparity and development of hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.5156-5156

2016

Volltextzugriff (PDF)

Overexpression of a Novel Activator of PAK4, the CDK5 Kinase―Associated Protein CDK5RAP3, Promotes Hepatocellular Carcinoma Metastasis

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8), p.2949-2958

2011

Volltextzugriff (PDF)

Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial- mesenchymal transition

Cancer research (Chicago, Ill.), 2006-10, Vol.66 (20), p.9948-9956

2006

Volltextzugriff (PDF)

P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (8), p.3601-3608

2007

Volltextzugriff (PDF)

Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression

Cancer research (Chicago, Ill.), 2006-09, Vol.66 (17), p.8367-8372

2006

Volltextzugriff (PDF)

Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (22), p.7646-7651

2003

Volltextzugriff (PDF)

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (19), p.8861-8868

2005

Volltextzugriff (PDF)

Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (14), p.5988-5996

2008

Volltextzugriff (PDF)

Role of a Novel Splice Variant of Mitotic Arrest Deficient 1 (MAD1), MAD1β, in Mitotic Checkpoint Control in Liver Cancer

Cancer research (Chicago, Ill.), 2008-11, Vol.68 (22), p.9194-9201

2008

Volltextzugriff (PDF)

Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor

Cancer research (Chicago, Ill.), 2002-08, Vol.62 (16), p.4711-4721

2002

Volltextzugriff (PDF)

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma

Cancer research (Chicago, Ill.), 2021-06, Vol.81 (12), p.3229-3240

2021

Volltextzugriff (PDF)

Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma

Cancer research (Chicago, Ill.), 2022-09, Vol.82 (17), p.3102-3115

2022

Volltextzugriff (PDF)

Abstract 3757: Examination of the epidermal growth factor 3 (HER3) dysregulations in hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3757-3757

2020

Volltextzugriff (PDF)

Abstract 6249: Single-cell RNA sequencing investigation of multi-stage NASH-related HCC mouse model

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6249-6249

2024

Volltextzugriff (PDF)

Abstract 2252: Overexpression of APOBEC3B enhances invasiveness of hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2252-2252

2015

Volltextzugriff (PDF)

Abstract 4772: Stearoyl-CoA Desaturase (SCD1) regulates liver tumor initiating cells through modulating ER stress

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4772-4772

2017

Volltextzugriff (PDF)

Abstract 3443: Functional and mechanistic characterization of oncogenic long intervening non-coding RNA Linc-CHD1L-1 in hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3443-3443

2017

Volltextzugriff (PDF)

Abstract 544: Hypoxia response signaling is linked to TACE resistance in hepatocellular carcinoma (HCC) patients

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.544-544

2017

Volltextzugriff (PDF)

Abstract 1986: IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1986-1986

2018

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Aktive Filter

KollektionSociological Abstracts

Zeitschrift / SerieHepatology

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(103)

Sprache

Englisch
(103)

Erscheinungsjahr

n.n

Kollektion

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Does the Hepatitis B Antigen HBx Promote the Appearance of Liver Cancer Stem Cells?

IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma

Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 Signaling

AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells

PAK4 Phosphorylates p53 at Serine 215 to Promote Liver Cancer Metastasis

Mechanisms through Which Hypoxia-Induced Caveolin-1 Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma

Abstract 5156: The roles of x-linked Midline 1 interacting protein 1 (MID1IP1) in gender disparity and development of hepatocellular carcinoma

Overexpression of a Novel Activator of PAK4, the CDK5 Kinase―Associated Protein CDK5RAP3, Promotes Hepatocellular Carcinoma Metastasis

Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial- mesenchymal transition

P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation

Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression

Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma

Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma

Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations

Role of a Novel Splice Variant of Mitotic Arrest Deficient 1 (MAD1), MAD1β, in Mitotic Checkpoint Control in Liver Cancer

Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma

Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma

Abstract 3757: Examination of the epidermal growth factor 3 (HER3) dysregulations in hepatocellular carcinoma

Abstract 6249: Single-cell RNA sequencing investigation of multi-stage NASH-related HCC mouse model

Abstract 2252: Overexpression of APOBEC3B enhances invasiveness of hepatocellular carcinoma

Abstract 4772: Stearoyl-CoA Desaturase (SCD1) regulates liver tumor initiating cells through modulating ER stress

Abstract 3443: Functional and mechanistic characterization of oncogenic long intervening non-coding RNA Linc-CHD1L-1 in hepatocellular carcinoma

Abstract 544: Hypoxia response signaling is linked to TACE resistance in hepatocellular carcinoma (HCC) patients

Abstract 1986: IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma

Aktive Filter

Suchergebnisse filtern